RECURRENCE RISK IN CHD

被引:5
作者
ZETTERQVIST, P [1 ]
机构
[1] KAROLINSKA HOSP,S-10401 STOCKHOLM,SWEDEN
关键词
D O I
10.1161/01.CIR.55.3.555
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:555 / 555
页数:1
相关论文
共 50 条
  • [31] All along the CHD/CVD risk watchtower
    Morabia, Alfredo
    Costanza, Michael C.
    PREVENTIVE MEDICINE, 2006, 43 (05) : 353 - 355
  • [32] Psychological distress, physical illness and risk of CHD
    Rasul, F
    Stansfeld, SA
    Hart, C
    Smith, GD
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 : 40 - 40
  • [33] Diabetic women at greater risk for CHD death
    不详
    GERIATRICS, 2006, 61 (03) : 13 - 13
  • [35] Ziprasidone vs olanzapine: Contrasts in CHD risk
    Leaderer, M
    Harrison, DJ
    Loebel, A
    Murray, S
    VALUE IN HEALTH, 2004, 7 (03) : 318 - 318
  • [36] RISK FACTOR FOR NAFLD AND CHD - SIMILARITY AND DIFFERENCES
    Pojskic, Lamija
    Stimjanin, Ena
    Selimovic, Harun
    Pojskic, Belma
    ATHEROSCLEROSIS, 2017, 263 : E259 - E259
  • [37] Predicting CHD risk in patients with diabetes mellitus
    Yeo, WW
    Yeo, KR
    DIABETIC MEDICINE, 2001, 18 (05) : 341 - 344
  • [38] Genetic determinants of plasma triglycerides and CHD risk
    Talmud, PJ
    Hawe, E
    Miller, GJ
    Humphries, SE
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 9 - 9
  • [39] Further improvements in CHD risk prediction for women
    Blumenthal, Roger S.
    Michos, Erin D.
    Nasir, Khurram
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (06): : 641 - 643
  • [40] Variables of the fibrinolytic system: Risk indicators for CHD
    JuhanVague, I
    Alessi, MC
    FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 : 47 - 49